F2 and pertussis: In our trial conducted in Zhejiang province, we found that after 6-year-old children were vaccinated with the co-purified DTaP, the seroconversion rate of anti-PT reached 81.20% (target value:70%), and both seropositive rates and antibody GMCs against pertussis (anti-PT and anti-FHA) increased significantly.